A Phase 4, Multicenter, Randomized, Double Blind, Placebo Controlled Pilot Study to Assess the Efficacy and Safety of H.P. Acthar Gel in Subjects With Pulmonary Sarcoidosis
Phase of Trial: Phase IV
Latest Information Update: 04 Nov 2019
Price : $35 *
At a glance
- Drugs Corticotropin (Primary)
- Indications Pulmonary sarcoidosis
- Focus Therapeutic Use
- Sponsors Mallinckrodt plc
- 16 Apr 2018 Planned End Date changed from 1 May 2021 to 1 May 2020.
- 16 Apr 2018 Planned primary completion date changed from 1 Nov 2020 to 1 Nov 2019.
- 30 Jan 2018 According to a Mallinckrodt plc media release, first patient has been enrolled.